Characterization of replication competent human immunodeficiency
Chimeric GB virus B (GBV-B)
Chimeric immunogenic gag-V3 virus-like particles of the human im
Cultivatable human rotavirus type 2
DNA constructs for retrovirus packaging cell lines
Dry-heat viral inactivation under controlled moisture conditions
Enhancement of oligonucleotide inhibition of protein production,
FVR vaccine
Genetically engineered attenuated double-stranded RNA viruses
Genetically engineered attenuated viruses
Genetically engineered human immunodeficiency virus-like particl
Hepatitis C virus ribozymes
Hepatitis-A viruses adapted to human fibroblast cells
Hepatitis-A viruses adapted to human fibroblast cells
Herpes simplex virus mutant UL41NHB
Herpes simplex virus-1 deletion variants and vaccines thereof
Herpes simplex virus-1 deletion variants and vaccines thereof
Herpesvirus pre-(viral DNA replication) enveloped particles
Identification of a human cytomegalovirus gene region involved i
Inactivated vaccines for aids and other infectious diseases